KEYWORDS
Treatment Considerations, Combination Therapy, Therapy Sequence, Biological Therapies, Bispecific Antibody Therapy, Immunotherapy, Adverse Events, Diseases, Lymphoid Malignancies, Lymphomas, Non-Hodgkin Lymphoma, B Cell Lymphoma, Indolent Lymphoma, Research, Clinical Research, Clinical Trials, Study Population, Human, Adult, Elderly